ONCY
Oncolytics Biotech
ONCY
ONCY
44 hedge funds and large institutions have $7.26M invested in Oncolytics Biotech in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $13.6M → $7.26M (-$6.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$540K | |
| 2 | +$154K | |
| 3 | +$135K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$75K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.9K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$115K | |
| 3 | -$73K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$48.8K |
| 5 |
Squarepoint
New York
|
-$25.6K |